RCUS
Arcus Biosciences Inc
Halal Rating :
Last Price
$14.02
Last updated:
Market Cap
-
7D Change
0.65%
1 Year Change
-7.21%
Company Overview
Industries
Exchange
Next Earnings Date
Arcus Biosciences is a clinical-stage biopharmaceutical company focused on developing innovative cancer immunotherapies. The company's primary business involves researching and developing novel drugs that help the immune system fight cancer. Their pipeline includes several promising candidates targeting various types of cancers, with a particular focus on immunotherapy combinations.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $48.0m | $154.0m | - | $1.0m | 0.00% | 0.65% |
| June 30, 2024 | $39.0m | $145.0m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $145.0m | $162.0m | - | $1.0m | 0.00% | 0.62% |
Company Impact
Help us evaluate Arcus Biosciences Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.